(VIANEWS) – Shares of ABL Diagnostics (CAC 40: ABLD.PA) fell by a staggering 33.33% in 21 sessions from €8.7 to €5.80 at 17:39 EST on Thursday, after five consecutive sessions in a row of losses. CAC 40 is rising 0.22% to €7,483.44, after three consecutive sessions in a row of losses.
About ABL Diagnostics
ABL Diagnostics Société anonyme does not have significant operations. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Paris, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.
Earnings Per Share
As for profitability, ABL Diagnostics has a trailing twelve months EPS of €-0.08.
Volatility
ABL Diagnostics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 22.48%, a negative 22.48%, and a positive 15.48%.
ABL Diagnostics’s highest amplitude of average volatility was 22.48% (last week), 22.48% (last month), and 15.48% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ABL Diagnostics’s stock is considered to be overbought (>=80).
More news about ABL Diagnostics (ABLD.PA).
